To earn trust, every day.
Adobe Flash Player version 9 (or greater) is required to view this banner. Click here to install the latest version of Flash.
Human Prescription - Cardiovascular Disease - Central Nervous System - Anesthesia - Immunology and Infectious Diseases - Oncology - Respiratory - Women's Health
Animal Health
Consumer Health Care
January 6, 2009Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
December 31, 2008Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
December 19, 2008Schering-Plough Provides Update on Dividend Payment Date for Mandatory Convertible Preferred Stock
December 12, 2008Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
December 10, 2008Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
December 8, 2008CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:
